Shows
OncotargetNew Hypothesis Links HPV E6 and SARS‑CoV‑2 Spike Proteins to Reduced p53 ActivityBUFFALO, NY – January 13, 2026 – A new #hypothesis article was #published in Oncotarget (Volume 17) on January 3, 2026, titled “Hypothesis: HPV E6 and COVID spike proteins cooperate in targeting tumor suppression by p53.”
Written by Wafik S. El-Deiry, Oncotarget Editor-in-Chief, from The Warren Alpert Medical School of Brown University and from Lifespan Health System and Brown University, the paper proposes that two viral proteins, HPV E6 and SARS-CoV-2 spike, could jointly reduce the activity of p53, a protein that helps protect cells from becoming cancerous. HPV is already known to drive several cancers, and the hypothesis suggests that additional pressure on p53 could matter for canc...
2026-01-1303 min
"En Plein Coeur", par un cardiologueLe COVID attaque aussi votre cœur et vos vaisseaux (et voici comment…) #SARS-CoV-2 #ACE2 #SRAA Le COVID-19 n’est pas qu’une maladie respiratoire 😮💨. En utilisant ACE2 🔑, le SARS-CoV-2 bouscule le système rénine-angiotensine-aldostérone (SRAA) : ➡️ Trop d’angiotensine II (🚀 accélérateur) ➡️ Pas assez d’angiotensine 1-7 (🛑 frein) 👉 Résultat : vasoconstriction 🩸, inflammation 🔥 et coagulation anormale 🧬Dans cet épisode 🎙️, je vous explique simplement ce mécanisme clé 🧩 — sans parler de symptômes ni de traitements — pour comprendre pourquoi le COVID-19 touche aussi le système cardiovasculaire ❤️🎯 Au programme (0% jargon, 100% clair) : ⚙️ Le SRAA expliqué simplement (rénine → angiotensine II → aldostérone) 🛡️ Rôle protecteur d’ACE2 et de l’an...
2025-09-2427 min
"En Plein Coeur", par un cardiologueun cardiologue vous parle des bases du SARS-CoV-2 et de son impact en cardiologie #covid🔴 Les bases du SARS-CoV-2 et son impact en cardiologie 🦠 Un virus respiratoire… qui touche aussi le cœur. Dans cet épisode, je vous explique simplement pourquoi le COVID-19 n’est pas seulement une maladie des poumons, mais une infection qui a profondément marqué la cardiologie.🫀 Au programme de cet épisode : 1️⃣ Qu’est-ce qu’un coronavirus ❓ 2️⃣ La structure du SARS-CoV-2 : protéine Spike 🔑, enveloppe 🧩, ARN viral 📜 3️⃣ Le rôle d’ACE2 🔒 et de l’enzyme TMPRSS2 ✂️ dans l’entrée du virus 4️⃣ Pourquoi ce virus a bouleversé notre compréhension de...
2025-09-1321 min
Deep Dive OnSARS-CoV-2 vaccine responseThis research investigated the durability of SARS-CoV-2 specific plasma cells generated after mRNA vaccination by examining bone marrow samples. The study found that, unlike influenza and tetanus, SARS-CoV-2-specific antibody secreting cells were largely absent from the long-lived plasma cell compartment in the bone marrow up to 33 months post-vaccination. Consequently, the waning of SARS-CoV-2 serum antibodies observed after vaccination could be attributed to this lack of establishment in the long lived compartment. The findings suggest that mRNA vaccines for SARS-CoV-2 do not induce the same durable plasma cell response in bone marrow as traditional vaccines, offering a potential explanation for the...
2025-08-0416 min
Base by Base️ 38: Viral Journeys — Tracing the Ancestral Bat Origins of SARS-CoV and SARS-CoV-2️ Episode 38: The Recency and Geographical Origins of Bat Viruses Ancestral to SARS-CoV and SARS-CoV-2 In this episode of Base by Base, we delve into a landmark study by Pekar et al. (2025) in Cell that harnesses recombination-aware phylogenetic and spatial analyses to trace how the closest bat coronavirus ancestors of SARS-CoV-1 and SARS-CoV-2 circulated mere years before spilling over into humans. By dissecting non-recombinant genomic segments and applying tailored molecular clock models, the authors reveal when and where these viral lineages emerged—and challenge past assumptions about transmission solely via bat host movement . Key highlights of the stud...
2025-06-0720 min
Heliox: Where Evidence Meets Empathy 🇨🇦3 of 3 SARS-CoV-2 Spike Protein, CD8+ T cells and Long COVIDSend us a textWelcome to the Heliox Podcast, where we unravel the mysteries of medical science together. On today's fascinating episode, we're diving into two groundbreaking studies that might help us understand the puzzle of long COVID. We'll explore how the virus's spike protein could affect blood clotting through an unexpected mechanism, and we'll look at how our immune system's memory cells behave over time in long COVID patients. What's particularly exciting is how these findings could explain some persistent symptoms and point to the continued importance of vaccination. Join us for a journey into the...
2024-10-2109 min
OncotargetSARS-CoV-2 Spike Protein Disrupts p53 Tumor Suppressor PathwayThe profound impact of the COVID-19 pandemic, caused by the SARS-CoV-2 virus, has been felt across various domains, including the realm of cancer research and treatment. As scientists delve deeper into the intricate mechanisms of this viral pathogen, intriguing revelations have emerged regarding its potential influence on cellular processes pivotal to cancer development and progression.
In a new study, researchers Wafik S. El-Deiry and Shengliang Zhang from Brown University and Lifespan Health System shed light on the intricate interplay between the SARS-CoV-2 spike protein and the tumor suppressor p53, a key guardian of genomic integrity. On May 3, 2024, they published their...
2024-05-0909 min
OncotargetTransfected SARS-CoV-2 Spike DNA Suppresses Cancer Cell Response to ChemotherapyBUFFALO, NY- May 6, 2024 – A new research paper was published in Oncotarget's Volume 15 on May 3, 2024, entitled, “Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure.”
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 infection has led to worsened outcomes for patients with cancer. SARS-CoV-2 spike protein mediates host cell infection and cell-cell fusion that causes stabilization of tumor suppressor p53 protein. In-silico analysis previously suggested that SARS-CoV-2 spike interacts with p53 directly but this putative interaction has not been d...
2024-05-0604 min
Criminal BehaviorologyLab Leak! Nicholas Wade and the Origin of SARS-CoV-2Criminal Behaviorology Lab Leak! Nicholas Wade and Origin of SARS-CoV-2The entire interview can be found on our YouTube channel: https://youtu.be/b-uyVPAnd5IThe views of our guests do not necessarily reflect those of Criminal Behaviorology, nor our sponsors. Nicholas Wade has written numerous books and articles on science. As the Science Editor for the New York Times (1990 to 1996) he possesses the skills necessary to sift through complicated ideas and arrive at the truth. When the COVID-19 (aka SARS-CoV-2) pandemic began, he soo...
2024-02-1545 min
Kanazawa University NanoLSI PodcastKanazawa University NanoLSI Podcast: Researchers identify the dynamic behavior of a key SARS-CoV-2 accessory proteinResearchers identify the dynamic behavior of a key SARS-CoV-2 accessory protein Hello and welcome to the NanoLSI podcast. Thank you for joining us today. In this episode we feature the latest research by Richard Wong at Kanazawa University alongside Noritaka Nishida at Chiba University.The research described in this podcast was published in the Journal of Physical Chemistry Letters in September 2023 Kanazawa University NanoLSI websitehttps://nanolsi.kanazawa-u.ac.jp/en/Researchers identify the dynamic behavior of a key SARS-CoV-2 accessory protein Researchers at...
2024-01-1206 min
Aging-USUnique Pathogenic Mechanism of SARS-CoV-2 Omicron Variant: Induction of Cellular SenescenceBUFFALO, NY- December 15, 2023 – A new #researchpaper was #published on the #cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 23, entitled, “Uncovering a unique pathogenic mechanism of SARS-CoV-2 omicron variant: selective induction of cellular senescence.”
SARS-CoV-2 variants are constantly emerging with a variety of changes in the conformation of the spike protein, resulting in alterations of virus entry mechanisms. Solely omicron variants use the endosomal clathrin-mediated entry.
In this new study, researchers Franziska Hornung, Nilay Köse-Vogel, Claude Jourdan Le Saux, Antje Häder, Lea Herrmann, Luise Schulz, Lukáš Radosa, Thurid Lauf, Tim...
2023-12-1504 min
The Viral TalkAsk a Professional series - SARS-CoV-2 variants with Wil FurnonThis is ‘Ask a professional’, the new format of the Viral Talk where the focus is on the science but most importantly the PERSON behind the science. From insect-borne viruses to SARS-CoV-2, we’re going to interview experts from the UK and the world on their research and then we’re going to talk about their career, future prospects and tips for younger generations of future scientists. In this episode Federico interviews Dr Wil Furnon, Post doctoral research associate at the Centre for Virus Research of the University of Glasgow. In this episode we’re going to talk about SARS-CoV-2...
2023-11-1624 min
CMAJ PodcastsRecommendations on SARS-CoV-2, influenza and RSV vaccinationsOn this episode, Drs. Mojola Omole and Blair Bigham speak with two vaccine experts about the necessity, timing and availability of vaccines as we move into the season when influenza, RSV and COVID-19 are on the rise.Dr. Scott Halperin, co-author of a CMAJ practice paper on SARS-CoV-2 vaccination in pregnancy, emphasizes the importance of vaccination to protect against COVID-19 infection during pregnancy. He notes that while there is awareness among healthcare practitioners, it is crucial to continually highlight and reemphasize the importance of vaccination during pregnancy. The risk of severe outcomes from COVID-19...
2023-11-1332 min
Black Headline NewsThe latest variant of SARS-CoV-2 to emerge on the scene, BA.2.86, is it dangerous?CDC is tracking a new SARS-CoV-2 variant called BA.2.86 and working to better understand its potential impact on public health. This update follows CDC’s initial risk assessment summary on August 23, 2023. A variant is an alternate version of a virus – in this case, the SARS-CoV-2 virus that causes COVID-19 – that has some mutations or changes in its genetic code, compared with the original. Mutations can alter the behavior of the viruses in various ways, such as how effectively they break into cells and how rapidly they can replicate, according to virologist and infectious disease expert, Dr. Suresh V. Kuchipudi.B...
2023-09-1302 min
Straight Talk MDValentin Bruttel: The Molecular Evidence pointing to a synthetic origin of SARS-CoV-2Molecular biologist and immunologist Valentin Bruttel discusses what he believes is compelling molecular evidence indicating SARS-CoV-2 was engineered in a lab. He is the co-author, along with Alex Washburne, and Tony VanDongen of the preprint entitled: Endonuclease fingerprint indicates a synthetic origin of SARS-CoV-2. He recently published a comprehensive analysis of the molecular evidence pointing to a lab origin of COVID-19 in a YouTube presentation entitled: SARS-CoV-2 Origin: How we were misled and how molecular evidence proves it came from a lab.
2023-06-053h 04
Acilci.Net - Sadece Video BölümleriAkut SARS-CoV-2 Enfeksiyonu Sonrası Nörolojik Sekellerin DeğerlendirilmesiGeçtiğimiz günlerde Amerikan Fiziksel Tıp ve Rehabilitasyon Akademisi (The American Academy of Physical Medicine and Rehabilitation-AAPM&R), akut SARS-CoV-2 enfeksiyonu sonrası sekel (PASC) olarak da bilinen uzamış COVID'li hastalarda nörolojik sekellerin değerlendirilmesi ve tedavisi hakkında yeni bir fikir birliği kılavuzu yayınladı. Bu yeni öneriler 16 Mayıs 2023’te Physical Medicine & Rehabilitation dergisinde, ABD'deki 41 uzamış COVID kliniğinde çeşitli tıbbi uzmanlık alanlarından uzmanlar arasındaki iş birliğinin sonucunda oluşturuldu.1 Bu yazımızda bu önerilere değineceğiz. Bu öneriler ele alınırken PASC konusunda efektif değerlendirme ve tedavinin limitli...
2023-05-3116 min
Acilci.Net - Ses ve Video Tüm BölümlerAkut SARS-CoV-2 Enfeksiyonu Sonrası Nörolojik Sekellerin DeğerlendirilmesiGeçtiğimiz günlerde Amerikan Fiziksel Tıp ve Rehabilitasyon Akademisi (The American Academy of Physical Medicine and Rehabilitation-AAPM&R), akut SARS-CoV-2 enfeksiyonu sonrası sekel (PASC) olarak da bilinen uzamış COVID'li hastalarda nörolojik sekellerin değerlendirilmesi ve tedavisi hakkında yeni bir fikir birliği kılavuzu yayınladı. Bu yeni öneriler 16 Mayıs 2023’te Physical Medicine & Rehabilitation dergisinde, ABD'deki 41 uzamış COVID kliniğinde çeşitli tıbbi uzmanlık alanlarından uzmanlar arasındaki iş birliğinin sonucunda oluşturuldu.1 Bu yazımızda bu önerilere değineceğiz. Bu öneriler ele alınırken PASC konusunda efektif değerlendirme ve tedavinin limitli...
2023-05-3116 minCMAJ PodcastsUnderstanding parents’ concerns about vaccinating their children against SARS-CoV-2Uptake of the SARS-CoV-2 vaccine for children aged 5–11 years has been lower than anticipated in Canada. Although research has explored parental intentions toward SARS-CoV-2 vaccination for children, the drivers of parents’ decisions to seek vaccination for their children - or not - have not been studied in-depth. A research paper published in CMAJ, entitled Parents’ perspectives on SARS-CoV-2 vaccinations for children: a qualitative analysis, sought to explore parents’ decision-making. It was a collaboration between physicians, social scientists and research scientists. On this episode, four of the paper’s authors discuss their findings with hosts, Drs. Omole and Bigh...
2023-02-2732 min
Podcastul Raportuldegardă.roBlocarea Infecției SARS-CoV-2 la Nivel Pulmonar | Dr. Marius Geantă | #știința360În ediția de pe 14 februarie 2023 a emisiunii #știința360, Dr. Marius Geantă, Președintele Centrului pentru Inovație în Medicină, a discutat despre identificarea unei proteine care blochează infecția cu SARS-CoV-2 la nivel pulmonar și formează o barieră protectoare naturală în organismul uman.
Proteina, numită LRRC15 (leucine-rich repeat-containing protein 15) funcționează ca un receptor care se leagă de SARS-CoV-2 și îl „sechestrează”, blocând progresia infecției. Studiul a fost realizat la Universitatea Syndey și reprezintă un punct de plecare important pentru cercetarea unei noi clase de medicamente pentru prevenția infecției cu SARS-CoV-2 sau alte coronavirusuri, dar și p...
2023-02-1626 min
BackTable ENTEp. 86 The Effects of the Omicron Variant of SARS-CoV-2 on Smell and the Immune Response with Dr. Puya Dehgani-MobarakiIn this episode of BackTable, Dr. Puya Dehgani-Mobaraki, president of Associazione Naso Sano, discusses his research and his experience as a rhinologist with SARS-CoV-2 and its effect on the olfactory system.---EARN CMEReflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/4UhYPr---SHOW NOTESFirst, Dr. Dehgani-Mobaraki explains the goals of the Associazione Naso Sano, which...
2023-01-2454 min
Stetoskopet – Tidsskriftets podkastRedaktørens hjørne #32: Tedrikking og dødelighet, den globale byrden av kreft, beskytter briller mot SARS-CoV-2?Nå foreligger det mer forskning på de første smitteutbruddene av SARS-CoV-2, der man blant annet har kunnet påvise at tidlige zoonotiske varianter av viruset må ha eksistert på våtmarkeder i Wuhan i flere år før pandemiens utbrudd. En annen nylig publisert studie har sett på forekomsten av sekveler etter SARS-CoV-2-infeksjon hos barn. Kan man stole på resultatet av neseprøver som barn tar selv? Og beskytter briller mot smitte?Den hittil største kohortstudien av apekoppertilfeller er nettopp publisert, og der finnes mye nyttig informasjon for de som jobber klinisk med denne pasientgruppe...
2022-09-0820 min
DiaszpóraPodcast Kemenesi Gáborral! Biológus, víruskutató és a Vírusvadászat - SARS-CoV-2 regény társírója 2022.06.17.Kemenesi Gábor (Budapest, 1987. szeptember 19.) Junior Prima díjas magyar biológus,víruskutató, a Pécsi TudományegyetemTermészettudományi Karának adjunktusa. Az egyetemen működő Szentágothai János Kutatóközpont Virológiai laboratóriumának munkatársa. A 2020-as COVID-19 világjárvány idején vált országosan ismertté, amikor a hazai médiában rendszeresen jelent meg a járvánnyal és a SARS-CoV-2 vírussal kapcsolatos témák szakértőjeként és a Koronavírus-kutató Akciócsoport tagjaként. 2013-ban végzett biológus szakon a Pécsi Tudományegyetem Természettudományi Karán. E...
2022-06-1741 min
COVID19 The AnswersEpisode 15 - Wastewater Surveillance of SARS-CoV-2Professor Alex MacKenzie MD, PhD, Dr Tyson Graber PhD, and Professor Robert Delatolla PhD talk about their research and work in detecting SARS-CoV-2 in the Wastewater of the citizens of Ontario, Canada.“SARS-CoV-2 Protein in Wastewater Mirrors COVID-19 Prevalence” - https://www.medrxiv.org/content/10.1101/2020.09.01.20185280v1“How sewage could reveal true scale of coronavirus outbreak” - https://www.nature.com/articles/d41586-020-00973-x/“Quantitative analysis of SARS-CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and prevalence” - https://www.sciencedirect.com/science/article/pii/S0043135420310952 “How Wastewater Tre...
2022-05-201h 03
Stetoskopet – Tidsskriftets podkastRedaktørens hjørne #26: SARS-CoV-2 hos dyr, behandling av akillesseneruptur, hiphop og helseDet er dessverre ikke uvanlig at helseinstitusjoner blir mål i krigsrammede områder, og vi ser også dette i Ukraina. Det foreligger enda mer forskning på covid-19-vaksinene, bivirkninger og immunitet. WHO oppfordrer dessuten til å være obs på at SARS-CoV-2 også forekommer blant ville dyr. Hvordan bør akillesseneruptur behandles? En sunn livsstil virker beskyttende mot å utvikle Alzheimers sykdom, men det øker også sjansen for å leve lenge. Når høy alder er en viktig risikofaktor for å utvikle Alzheimers sykdom, betyr det at de to utjevner hverandre? Og hva har hiphop og helse med hverandre å gjøre? Are Brean fortelle...
2022-04-2818 min
FisicastFisinews #018 - Sensores quânticos para detectar SARS-CoV-2, buracos negros induzindo a criação de estrelas e computadores quânticos vs clássicosFala pessoal,
Mais um episódio de notícias quentinhas! Nessa edição, o Sato e o Hítalo falaram de buracos negros possivelmente induzindo a criação de estrelas, algoritmos sendo desenvolvidos para computadores clássicos tentando equiparar à velocidade de processamento dos computadores quânticos, e a última notícia foi sobre resultados de simulação de sensores quânticos sendo utilizados para a detecção de SARS-CoV-2, o vírus responsável pelo Covid-19. Vem ouvir e descobrir!
1) Buracos negros induzindo a criação de estrelas
https://www.nasa.gov...
2022-03-1439 min
Drug Target Review PodcastEpisode 6 - mAbs and SARS-CoV-2 with Dr Carter Mitchell & Dr Sharath Madasu, Kemp ProteinsIn this episode of Drug Target Review’s podcast, in association with Molecular Devices, Editor Victoria Rees speaks with Dr Carter Mitchell, Chief Science Officer at Kemp Proteins and Dr Sharath Madasu, Manager of Protein Characterisation at Kemp Proteins about the use of monoclonal antibodies (mAbs) against SARS-CoV-2 and why the workflow to develop these biologics has changed over the course of the pandemic.
The speakers began by explaining why mAbs are useful against SARS-CoV-2 and how they work to neutralise the virus.
"In particular with SARS-CoV-2, you want to disrupt the binding of spike proteins with ACE2 receptors and mo...
2022-02-2228 min
Protect our Province AlbertaNational Edition: Lessons from SARS-CoV-1Michelle is joined by:
Dr. Lyne Filiatrault (Retired Vancouver Emergency Physician and PoPBC Member)Mario Possamai (Senior Advisor, SARS Commission)Matt Oliver
The panel discusses what we learned from SARS-CoV-1 (2003 SARS pandemic) and what we did and didn’t apply going into SARS-CoV-2 (COVID-19).
Presentation: SARS: Not your regular shift in the ED
Presenter: Dr. Lyne Filiatrault
Loading…
Taking too long?
Reload document
|
Open in new tab
Presentation: A Study in Hubris
Presenter: Mario Possamai
Loading…
Taking too long?
2022-02-031h 10
CORONAVIRUS. COVID-19125-ÓMICRON: VARIANTE DE LA SARS-COV-2. CON PATOGENICIDAD REDUCIDA EN HÁMSTERES.La organización bioRxiv publica el 03 de enero de 2022, un preimpreso llamado. “Patogenicidad reducida de la variante Ómicron SARS-CoV-2 en hámsteres”.
En este documento refiere que la variante SARS-CoV-2 Ómicron ha demostrado ser altamente transmisible y ha superado a la variante Delta en muchas regiones del mundo. Los primeros informes también han sugerido que Ómicron puede resultar en una enfermedad clínica menos grave en humanos. El articulo muestra que Ómicron es menos patógeno que las variantes anteriores del SARS-CoV-2 en hámsteres dorados sirios. La infección de hámsteres con las cepas SARS-CoV-2 WA1/20...
2022-01-1603 min
American StatesmanElection 2022 - A Battle Against SARS-CoV-2 - COVID-19 Attack Against the U.S.A.Election 2022 will determine if the United States of America will defeat the SARS-CoV-2 war bio-weapon war againt the free world and restore our personal liberty and rights or if we will fall to a global takeover and lose our country. We must get involved NOW!! Americans must face the truth. SARS-CoV-2 aka COVID-19 was and still is an attack on the United States of America. We must demand honesty from every elected public servant. We must demand they take action to defeat this war on our homeland. Our government is attacking Americans. 1) Americans denied viable treatments for SARS-CoV-2. Depopulation - aka M...
2022-01-052h 53American StatesmanElection 2022 - A Battle Against SARS-CoV-2 - COVID-19 Attack Against the U.S.A.Election 2022 will determine if the United States of America will defeat the SARS-CoV-2 war bio-weapon war againt the free world and restore our personal liberty and rights or if we will fall to a global takeover and lose our country. We must get involved NOW!! Americans must face the truth. SARS-CoV-2 aka COVID-19 was and still is an attack on the United States of America. We must demand honesty from every elected public servant. We must demand they take action to defeat this war on our homeland. Our government is attacking Americans. 1) Americans denied viable treatments for SARS-CoV-2. Depopulation - aka M...
2022-01-052h 53
Dr Robert Hess answers the latest questions on the pandemicDr Robert Hess: How do viruses – and more particularly SARS-CoV-2 – interfere with the p53 pathway?We look at the strategies employed by viruses against this tumor suppressor gene.
Since the onset of the pandemic, research has been conducted into the extent to which SARS-Cov-2 affects the p53 tumor suppressor gene and its pathway. Two widely published studies from 2020 and 2021 have provided interesting insights into this, revealing the molecular strategies by means of which viruses such as SARS-CoV-2 target the p53 function.
It is also interesting to compare the combat strategies of other viruses with those of SARS-CoV-2, and we will also briefly discuss this below.
2021-12-2210 min
MS-SelfieIs Omicron a new variant or a new strain of SARS-CoV-2?I am aware that a lot of you are very uncertain about what to do regarding Omnicron and the different advice you have been given about vaccines, shielding, DMT usage and COVID-19 treatments and some of the terms used by the scientific and medical community. On top of this is the Infowars between public health professionals, their governments and the nefarious agents peddling misinformation and disinformation about COVID-19 and the COVID-19 vaccines. Many of you are also confused about the use of the terms mutation, variant and strain, which are often used interchangeably. Mutation vs. Variant vs. S...
2021-12-2115 min
The Nonlinear Library: LessWrong Top PostsCredibility of the CDC on SARS-CoV-2 by Elizabeth, jimrandomhWelcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio.This is: Credibility of the CDC on SARS-CoV-2, published y Elizabeth, jimrandomh on the LessWrong.IntroductionOne of the main places Americans look for information on coronavirus is the Center for Disease Control and Prevention (abbreviated CDC from the days before “and Prevention” was in the title). That’s natural; “handling contagious epidemics” is not their only job, but it is one of their primary ones, and they position themselves as the authority. At a time when so many thing...
2021-12-1210 min
Editors in ConversationSARS-CoV-2 Sequencing for Clinical Care and Infection ControlIs sequencing the SARS-CoV-2 genome useful for patient care? What about institutional infection control? And if clinical labs decide to perform SARS-CoV-2 sequencing, how should they do it? How should they report the results? And will they get paid? Until recently, sequencing of SARS-CoV-2 genomes has mainly been done in public health or research laboratories. Now, there is increasing interest in sequencing the viral genome in healthcare settings for uses in patient care and infection control. We'll be talking about a new guideline that can help clinical labs and institutions decide whether to perform SARS-CoV-2 sequencing.
2021-11-2949 min
Biologists Being BasicSARS-CoV-2 VaccinesThe B3 team is back for an episode discussing SARS-CoV-2 vaccines. B3 hosts Robyn and Kelsey are joined by their colleagues Drs. Lorena Zuliani-Alvarez and Ujjwal Rathore, and their guest Laura Gladson, to talk about what vaccines are, as well as our own experiences in getting vaccinated against SARS-CoV-2. Then we take a look at the common misconceptions, and try to address frequently asked questions regarding SARS-CoV-2 mRNA vaccines.
For a full transcript, please visit our website’s transcript page where you can find both the online and downloadable versions. http://biosbeingbasic.podomatic.net/transcripts.
If you have any questions or...
2021-11-241h 27
Kunapipi podcastCepiva proti SARS-Cov-2Cepivo proti covidu-19 je cepivo, namenjeno zagotavljanju pridobljene imunosti proti virusu SARS-CoV-2.
Ključnega pomena pri cepivih je naše zaupanje v varnost in učinkovitost cepiv, katerih zaupanje najprej temelji na jasni in objektivni obveščenosti.
Gostja v tokratni podcasta Kunapipi je prof. dr. Mojca Narat, imunologinja in predstojnica Katedre za genetiko, animalno biotehnologijo in imunologijo na Oddelku za zootehniko ter vodja kolegija študija Biotehnologija na Biotehniški fakulteti Univerze v Ljubljani.
Z njo se pogovarjamo o temah kot so:
=> Zakaj je pri nas tako malo dobrih znanstvenih komunikatorjev na temo ce...
2021-10-051h 57
Podcast vozypensamiento¡¡Bombazo!! Sanidad reconoce que “no dispone de cultivo de SARS-COV-2” ni “registro de laboratorios coPDF EN: https://t.me/descargaydistribuye/2193 * en DRIVE https://drive.google.com/file/d/1Uq882I25sKb6hN6I2NYTTP-GXszGhYqS/view?usp=sharing
¡¡Bombazo!! Sanidad reconoce que “no dispone de cultivo de SARS-COV-2” ni “registro de laboratorios con capacidad de cultivo y aislamiento para ensayos”
Por
El Diestro https://www.eldiestro.es/2021/09/bombazo-sanidad-reconoce-que-no-dispone-de-cultivo-de-sars-cov-2-ni-registro-de-laboratorios-con-capacidad-de-cultivo-y-aislamiento-para-ensayos/
-
30 septiembre, 2021
La farsa se está empezando a desmoronar y ya no sabemos qué es lo que se van a inventar desde el gobierno, medios de manipulación masiva y sanitarios vendidos para seguir vendiéndonos la moto de un virus que parece más falso que la tesis de...
2021-09-3002 minPodcast vozypensamiento¡¡Bombazo!! Sanidad reconoce que “no dispone de cultivo de SARS-COV-2” ni “registro de laboratorios coPDF EN: https://t.me/descargaydistribuye/2193 * en DRIVE https://drive.google.com/file/d/1Uq882I25sKb6hN6I2NYTTP-GXszGhYqS/view?usp=sharing
¡¡Bombazo!! Sanidad reconoce que “no dispone de cultivo de SARS-COV-2” ni “registro de laboratorios con capacidad de cultivo y aislamiento para ensayos”
Por
El Diestro https://www.eldiestro.es/2021/09/bombazo-sanidad-reconoce-que-no-dispone-de-cultivo-de-sars-cov-2-ni-registro-de-laboratorios-con-capacidad-de-cultivo-y-aislamiento-para-ensayos/
-
30 septiembre, 2021
La farsa se está empezando a desmoronar y ya no sabemos qué es lo que se van a inventar desde el gobierno, medios de manipulación masiva y sanitarios vendidos para seguir vendiéndonos la moto de un virus que parece más falso que la tesis de...
2021-09-3002 minPodcast vozypensamiento¡¡Bombazo!! Sanidad reconoce que “no dispone de cultivo de SARS-COV-2” ni “registro de laboratorios coPDF EN: https://t.me/descargaydistribuye/2193 * en DRIVE https://drive.google.com/file/d/1Uq882I25sKb6hN6I2NYTTP-GXszGhYqS/view?usp=sharing
¡¡Bombazo!! Sanidad reconoce que “no dispone de cultivo de SARS-COV-2” ni “registro de laboratorios con capacidad de cultivo y aislamiento para ensayos”
Por
El Diestro https://www.eldiestro.es/2021/09/bombazo-sanidad-reconoce-que-no-dispone-de-cultivo-de-sars-cov-2-ni-registro-de-laboratorios-con-capacidad-de-cultivo-y-aislamiento-para-ensayos/
-
30 septiembre, 2021
La farsa se está empezando a desmoronar y ya no sabemos qué es lo que se van a inventar desde el gobierno, medios de manipulación masiva y sanitarios vendidos para seguir vendiéndonos la moto de un virus que parece más falso que la tesis de...
2021-09-3002 min
Dr Robert Hess - Ready for the battle?Dr Robert Hess comments about recent studies relating autoantibodies against interferon-I and a SARS-CoV-2 infectionDoctor Robert Hess comments about recent studies that have established a strong link between the presence of autoantibodies against interferon-I and a severe progression of disease after infection with SARS-CoV-2.
As we have explained in previous Keynotes, our body’s own interferon system plays an important role in the activation and modulation of the immune defenses. In this update, we will focus on what happens when there is a failure to activate the type I interferons (IFN-I) and on the risks that this poses. IFN-I is of immense importance in relation to the body’s own virus defense and thus highl...
2021-09-1703 min
Rapid SequenceSARS-CoV-2 infection and venous thromboembolism after surgeryRobust evidence is needed to enable clinicians and policymakers to minimise VTE risk in patients with SARS-CoV-2 infection. Ideally, such evidence would stratify the risk of VTE against both the duration of time between infection and surgery and presence or absence of symptoms. This study aimed to determine the VTE rate in patients with SARS-CoV-2 infection, stratified by current or prior infection.
The authors found that SARS-CoV-2 infection was independently associated with an increased incidence of postoperative VTE in patients with peri-operative and recent SARS-CoV-2 infection. In patients with pre-operative SARS-CoV-2, ongoing symptoms were associated with an...
2021-08-3031 min
АНТРОПОГЕНЕЗ.РУКонспирология эпидемий ВИЧ и SARS-CoV-2. Как отличить искусственный вирус? Александр Панчин. Ученые против мифов 15-7Сложно не заметить параллели между развитием теорий о лабораторном происхождении ВИЧ в секретных лабораториях США и конспирологическими версиями происхождения коронавируса SARS-CoV-2 в лабораториях Китая. Вирусы изменились, а вот аргументы конспирологов – едва ли.
Очень хочется отделить правду от вымысла и понять, какой информации о происхождении вирусов ВИЧ и SARS-CoV-2 можно доверять!
ПОДПИШИСЬ НА НОВЫЕ ЭПИЗОДЫ ► https://clck.ru/H4hGu
Поддержите нас на Patreon ► https://www.patreon.com/bePatron?c=1920060
================
Научно-просветительский Форум «Ученые против мифов-15»
https://antropogenez.ru/forum15-itogi/
19-20 июня 2021 г.
Часть-7. Александр Панчин — биоинформатик, к. б. н., лауреат премии «Просветитель» за книгу «Сумма биотехнологии».
Доклад «Конспирология эпидемий ВИЧ и SARS-CoV-2. Как отличить искусственный вирус?»
Вредный оппонент: Константин Лесков — Ph. D., Case Western Reserve University, Cleveland, OH.
0:00 Начало
0:42 Голосование зрителей «Какую версию происхождения CARS-CoV-2 вы считаете наиболее вероятной?»
1:30 История эпидемий конспирологии
4:44 Почему происхождение вирусов важно?
6:48 Теория заговора или научная гипотеза?
11:50 Коронавирус имеет сходство с ВИЧ
13:38 Коронавирус не гибрид из статьи в Nature Medicine
14:33 Коронавирус - гибрид коронавирусов от летучем мыши и панголинов?
20:13 Фуриновый сайт CARS-CoV-2
22:56 Учёные умеют синтезировать даже геномы бактерий
24:00 Утечка не равно создание
29:44 Выводы
31:32 Результаты онлайн-голосования «Какую версию происхождения CARS-CoV-2 вы считаете наиболее вероятной?»
31:06 Дискуссия со “вредным” оппонентом — генетиком Константином Лесковым
44:18 Список литературы
46:44 Голосование зрителей «Как вы оцениваете “вредность” оппонента (Константин Лесков)?»
47:48 Ответы на вопросы слушателей
57:35 Выбор лучшего вопроса
58:36 Результаты голосования зрителей о “вредности” оппонента - Константина Лескова
59:08 Анонс состязания «Наука на пальцах». Битва археологов
📖 Стенограмма доклада: https://vk.com/@antropogenez_ru-konspirologiya-epidemii
================
Организатор форума: АНТРОПОГЕНЕЗ.РУ
Запись, монтаж: "Лаборатория Научных Видео" @ScienceVideoLab
Площадка в Москве предоставлена НИТУ "МИСиС"
Юридическая поддержка: адвокатское бюро CTL https://abctl.ru
🦈 GEN.RU: поставщик уникальных принтов и гаджетов для форума https://stopmyth.gen.ru
Ведущий: Александр Соколов, редактор АНТРОПОГЕНЕЗ.РУ
Музыка: Константин Устинович, Дмитрий Денисов https://vk.com/alt_sound
Дизайн: Ирина Фролова, Ирина Галенкова
Стенограмма: SciTeam
Диктор: Евгений Прохоров
Видео-заставка: Виталий Краусс, Тимур Низов
Анимация: Тимур Низов
Скетч: Юлия Родина
Видеорежиссер: Виталий Краусс
Звукорежиссер: Ксения Аблез
Оператор-постановщик: Пётр Стерликов
Продюсер: Георгий Соколов
Координатор: Мариша Эрина
========================
⚠ Поддержать проект: http://antropogenez.ru/how-to-help/
2021-08-201h 00
CORONAVIRUS. COVID-19102-VARIANTES DEL SARS-COV-2. CUALES SON Y COMO LAS CLASIFICA LA OMS.El objetivo de este episodio es aprender sobre las variantes del SARS-CoV-2. Y como las clasifica la OMS.
Todos los virus, incluido el SARS-CoV-2, el virus que causa COVID-19, cambian con el tiempo. La mayoría de los cambios tienen poco o ningún impacto en las propiedades del virus. Sin embargo, algunos cambios pueden afectar las propiedades del virus, como la facilidad con que se propaga, la gravedad de la enfermedad asociada, el rendimiento de vacunas, medicamentos terapéuticos, herramientas de diagnóstico u otras medidas sociales y de salud pública.
¿Cu...
2021-08-1508 min
Dr Robert Hess - Ready for the battle?Dr Robert Hess and his SARS-CoV-2 Task Force: As we have long maintained, the direction taken by the pandemic ...will be determined by the genetics of the SARS-CoV-2 virus itself. The prospects for success in defeating the pandemic in 2021 are therefore uncertain.
SARS CoV-2 Task Force: As we have long maintained, the direction taken by the pandemic will be determined by the genetics of the SARS CoV-2 virus itself. The prospects for success in defeating the pandemic in 2021 are therefore uncertain.
2021-07-1809 min
This Week in VirologySARS-CoV-2 fitness with Ron FouchierRon Fouchier explains why increased transmission of SARS-CoV-2-variants has not been demonstrated, and their ability to displace ancestral variants is due to greater fitness, much like influenza virus antigenic variation leads to better fitness and replacement of previously circulating variants. Hosts: Vincent Racaniello, Kathy Spindler, and Brianne Barker Guest: Ron Fouchier Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Ron Fouchier on TWiV 177, 291, 557 Mutations driving H5N1 airborne transmission in ferrets (Cell) SARS-CoV and SARS-CoV-2 transmission among ferrets (Nat Comm) Av...
2021-07-081h 36CORONAVIRUS. COVID-1995-TRANSMISIÓN DEL SARS-COV-2. CAMBIOS RECIENTES. CDC. ACTUALIZACIÓN A LA FECHA.Este informe científico se ha actualizado el 7 de mayo de 2021. Para reportar los conocimientos actuales sobre la transmisión del SARS-CoV-2 y se ha reformateado para que sea más conciso.
PRIMERA: El SARS-CoV-2 se transmite por exposición a fluidos respiratorios infecciosos.
SEGUNDA: Las exposiciones infecciosas a los fluidos respiratorios que transportan el SARS-CoV-2 ocurren de tres formas principales (no mutuamente excluyentes):
TERCERA: El riesgo de infección por SARS-CoV-2 varía según la cantidad de virus a la que está expuesta una persona.
CUARTA: Puede ocurrir la transmisi...
2021-06-2709 min
Discovery and ResearchUncovering Genomic Evidence of SARS-CoV-2 Infection and ReinfectionIs it possible to become reinfected with SARS-CoV-2? If so, how can we identify and confirm reinfection? What tools can we use to better identify prevalent and emerging strains of SARS-CoV-2?
Joel Sevinsky, Principal at Theiagen Consulting, is an expert in bioinformatics in the public health space and coauthor of a recent paper exploring the genomics evidence for reinfection with SARS-CoV-2 that was published in The Lancet Infectious Diseases. In this webinar, Dr. Sevinsky will discuss:
How next-generation sequencing (NGS) and off-the-shelf software confirmed the first documented SARS-CoV-2 reinfection case in the United States;
2021-06-1752 minThis Week in VirologySARS-CoV-2 origins with Peter Daszak, Thea Kølsen Fischer, Marion KoopmansPeter Daszak, Thea Kølsen Fischer, and Marion Koopmans, members of the WHO team investigating the origins of SARS-CoV-2 join TWiV to explain the work done by the committee during phase one, their conclusions, and the extent of work that remains to be done in phase two. Hosts: Vincent Racaniello, Rich Condit, and Kathy Spindler Guests: Peter Daszak, Thea Kølsen Fischer, and Marion Koopmans Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Peter on TWiV 615, 623 Thea on TWiV 576 Marion on TWiV 41...
2021-05-271h 27
FrancoinformadorEl 'talón de Aquiles' del Sars CoV-2.HALLAZGO ESPERANZADOR. El 'talón de Aquiles' del Sars CoV-2. Según informó la televisión suiza RTS, el equipo científico de la Universidad Politécnica Federal de Zúrich, en colaboración con expertos de las universidades de Berna, Lausana y Cork (Irlanda), consiguió hallar un método teórico para frenar el mecanismo de producción de proteínas que podría ser la base para futuros fármacos contra el coronavirus SARS-CoV-2. El freno a la producción de proteínas reduciría la réplica viral del SARS-CoV-2 en células infectad...
2021-05-1908 min
A Tale of Two Hygienists PodcastFast Facts: Perio Edition "SARS-CoV-2 And The Mouth"On this week's episode of Fast Facts - Perio Edition your host, Katrina Sanders, RDH talks to us about the latest information about COVID-19 and a link between SARS-CoV-2 and the mouth, researched by the National Institute of Health. Quotes: "The scientists within the NIH actually gathered samples of the cells, of the mouths of individuals who lost their life to SARS-CoV-2 of course, they found that SARS-CoV-2 was in the lungs or even potentially in the digestive system, but what they found was in a bulk majority of these individuals, SARS...
2021-05-1704 minA Tale of Two Hygienists PodcastFast Facts: Perio Edition "SARS-CoV-2 And The Mouth"On this week's episode of Fast Facts - Perio Edition your host, Katrina Sanders, RDH talks to us about the latest information about COVID-19 and a link between SARS-CoV-2 and the mouth, researched by the National Institute of Health. Quotes: "The scientists within the NIH actually gathered samples of the cells, of the mouths of individuals who lost their life to SARS-CoV-2 of course, they found that SARS-CoV-2 was in the lungs or even potentially in the digestive system, but what they found was in a bulk majority of these individuals, SARS...
2021-05-1704 min
Discovery and ResearchSARS-CoV-2 NGS surveillance & epidemiology with QIAGEN Digital InsightsThis one-hour event will summarize our solutions for genomics research, environmental testing, and epidemiological study of SARS-CoV-2 NGS data, including:
Local and high-performance cloud (GCE) deployment
• Workflows for analyzing SARS-CoV-2 data using CLC Genomics software and focused approaches such as QIAseq SARS-CoV-2 Primer and Ion AmpliSeq SARS-CoV-2 panels.
• Analysis features, such as read mapping, consensus sequence, variant calling, and visualizations for efficient interpretation and cross-sample comparisons.
• Demonstration of local and cloud-based configurations of the CLC Genomics Server (GCE).
Fully Automated Analysis Service QIAGEN CoV-2 Insights Service
• Automated, high-thr...
2021-05-141h 02
PKMK FK-KMK UGMCovid Talks 3: Identifikasi Mutasi Virus SARS-Cov-2 di IndonesiaNarasumber: dr. Slamet, MHP (Kepala Badan Litbangkes)
Moderator: dr. Eta Auria Latiefa
Podcast episode ini membahas mengenai penyebab mutasi virus, tahapan proses identifikasi mutasi virus SARS Cov 2, perkembangan terkini identifikasi mutasi SARS Cov 2 dari India, dan varian SARS Cov 2 yang sudah teridentifikasi di Indonesia.
2021-05-1026 min
EPIDEMIC with Dr. Celine GounderS1E71 / Is SARS-CoV-2 Here to Stay? / Jennie Lavine, Angela Rasmussen, Jeffrey Shaman"I don't think that herd immunity is a possibility for SARS CoV-2. I think there's going to be a different kind of equilibrium that we reach in the future where humans and SARS-CoV-2 co-exist in a much milder, more benign way." -Jennie LavineThe end of the pandemic might not mean the end of SARS-CoV-2. In fact, many scientists think COVID is here to stay, even with vaccines. In this episode we'll hear why we may never reach herd immunity, how the coronavirus could change over time, and why kids are the key to reducing the severity o...
2021-04-2220 min
Biologists Being BasicUpdates on SARS-CoV-2 Part 2In our second episode revisiting SARS-CoV-2 research we examine how SARS-CoV-2 infects cardiac cells and causes damage to the heart. We talk to co-authors Sarah Rockwood, Dr. Juan Perez-Bermejo, and Dr. Serah Kang about how they use induced pluripotent stem cells to study the effects of SARS-CoV-2 on heart tissue.
News coverage of this study, and the STAT article that is referenced during the episode can be found here:
https://abc7news.com/covid-heart-damage-palpitations-san-francisco-gladstone-institutes-attack/10433711/
https://www.statnews.com/2020/09/04/carnage-in-lab-dish-shows-how-coronavirus-may-damage-heart/
The primary peer-reviewed research article, published in Science Translational Medicine, titled “SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in...
2021-04-211h 02CORONAVIRUS. COVID-1972-PUEDO REINFECTARME CON EL CORONAVIRUS, SI YA ME DIO LA INFECCIÓN O SI YA ME VACUNARON CONTRA EL SARS-CoV-2. ECDC. ACTUALIZACIÓN A LA FECHA.Con respecto a la transmisión de personas previamente infectadas, se concluyeron los siguientes 4 puntos clave:
1-Ningún estudio midió directamente la transmisión del SARS-CoV-2 de personas reinfectadas a sus contactos.
2-Sin embargo, hubo evidencia que muestra que las reinfecciones son raras.
3-Los estudios que han seguido a personas durante 5 a 7 meses después de la recuperación de una infección por SARS-CoV-2 han estimado que el efecto protector de una infección previa por SARS-CoV-2 es muy alto (81% - 100%) durante ese período.
4-Sin embargo, debe tenerse en cuenta qu...
2021-04-0406 minThis Week in VirologySARS-CoV-2 in NYC wastewaterJohn, Monica, and Davida join TWiV to discuss development of a method to detect SARS-CoV-2 in raw sewage from all 14 of New York City’s treatment plants, and its use to determine the presence of the genome throughout the pandemic and detection of genome mutations from variants of concern. Hosts: Vincent Racaniello, Dickson Despommier, Rich Condit, and Kathy Spindler Guest: John Dennehy, Davida Smyth, and Monica Trujillo Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Protocol for detecting SARS-CoV-2 RNA in wastewa...
2021-04-011h 55
Biologists Being BasicUpdates on SARS-CoV-2 Part 1In this episode we revisit SARS-CoV-2 research and take a look at new studies that have built on the work completed early in the pandemic. We focus on a story featuring Plitidepsin, a cancer drug that is being repurposed and tested in clinical trials to treat SARS-CoV-2 infection. This discussion features B3 hosts Gina, Mehdi and Robyn who are joined by scientists Dr. Lucy Thorne and Dr. Ann-Kathrin Reuschl.
You can find the first article that was published in Science, “Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A” here: https://science.sciencemag.org/content/371/6532/926
You...
2021-03-311h 04
La Maldita Primavera 2020. #cienciaporcientíficas en #COVID-19 #scicomm #LMP #cienciaciudadanaLMP3#4. Dra. Jazmin García Machorro - científica en virus y vacunas- . Las particularidades del Sars-Cov-2 y la enfermedad covid-19.El Sars-CoV-2 y las vacunas en México, desde el punto de vista de una investigadora en vacunas. Una conversación indispensable con una investigadora cuyo perfil, conocimientos y experiencia son los mas adecuados para conocer al virus de covid-19.
e-mail: jazzgama@hotmail.com, jgarciama@ipn.mx
Alumnos graduados: 1 de doctorado, 5 de maestría, 8 de especialidad médica.
Proyectos de Investigación:
Responsable técnico de 8 proyectos de investigación en virus (influenza, dengue, Zika y Chikungunya).
Responsable técnico de proyecto CONACYT número
312807 denominada “Caracteriza...
2021-02-2148 min
Future Science GroupCOG-UK: sequencing SARS-CoV-2 and detecting the novel variant B.1.1.7This episode takes a look at the role the COVID-19 Genomics UK Consortium (COG-UK) has played sequencing SARS-CoV-2 and surveying for COVID-19. To do this I speak to two key members of the consortium; Steve Paterson, Professor of genetics at the University of Liverpool and lead for the wastewater working group of COG-UK; and Josh Quick, Future Leaders Fellow at the University of Birmingham and lead at the COG-UK Sequencing working group.
Steve discusses some of the techniques required to detect SARS-CoV-2 in wastewater, the challenges that such a vibrant sample can present, and gives his account of the part...
2021-02-1834 min
Talking TechniquesCOG-UK: sequencing SARS-CoV-2 and detecting the novel variant B.1.1.7This episode, supported by Tecan, takes a look at the role the COVID-19 Genomics UK Consortium (COG-UK) has played sequencing SARS-CoV-2 and surveying for COVID-19. To do this I speak to two key members of the consortium; Steve Paterson, Professor of genetics at the University of Liverpool and lead for the wastewater working group of COG-UK; and Josh Quick, Future Leaders Fellow at the University of Birmingham and lead at the COG-UK Sequencing working group.Steve discusses some of the techniques required to detect SARS-CoV-2 in wastewater, the challenges that such a vibrant sample can present...
2021-02-1834 min
Luis Rojas - Bio Cleaning ConsultingSurface Stability of SARS-CoV-2 as Compared to with SARS-CoV-1We evaluated the stability of SARS-CoV-2 and SARS-CoV-1 in aerosols and on various surfaces and estimated their decay rates using a Bayesian
regression model.
Interesting Article by the Th e new England Journal of Medicine.
Let me know your thoughts
Remember we are here to share and serve.
Best regards,
Luis
luis@bio-cleaning.com.au
www.bio-cleaning.com.au
2021-02-1619 min
Micro binfie podcast47 SARS-CoV-2 Rapid roundup and questions answeredWe present a rapid round up of SARS-CoV-2 questions and issues, hopefully with some answers, so that you can stay on top of the latest in SARS-CoV-2 genomics. Recorded 5 February 2021.
Topics covered:
Why missing 1 SNP can cause lineage assignment to break and how it works?
How do we describe lineages with a chain of mutation events?
Are we seeing convergent evolution?
Co-infections of different lineages discovered?
For nanopore basecalling do use HAC & should you get a GPU?
Basic logistics difficult for sequencing in many parts of world.
Can I look at recombination with ARTIC on Illumina?
How do you annotate...
2021-02-0832 min
Unbiased ScienceCh-Ch-Ch-Ch-Changes (Turn and Face the Strains): SARS-CoV-2 MutationsOn this week's episode we discuss mutations, specifically in the context of SARS-CoV-2. We set the stage by describing what a mutation is and how this random process occurs in all organisms. We discuss the emergence of SARS-CoV-2 and a primer on zoonotic diseases before focusing on mutation rates of SARS-CoV-2, and comparison to another RNA virus, influenza virus. We talk about the key mutations of the variants of concern B.1.1.7, B.1.351, and P.1 and the spike antigen of the virus, and why these mutations have become more prevalent. We wrap up with a discussion on the implications of...
2021-02-0837 min
The Unspeakeasy With Meghan DaumWho's Afraid Of The Lab-Leak Hypothesis? Dr. Alina Chan and Dr. Filippa Lentzos On The Possible Origins Of The SARS-CoV-2 VirusSince the beginning of the coronavirus pandemic, the prevailing wisdom from government officials and much of the scientific community is that the SARS-CoV-2 virus originated in an animal and at some point jumped to humans. The idea that it might have accidentally escaped from a lab has been widely dismissed as conspiracy theory, partly because it was easily conflated with inflammatory rhetoric coming out of the Trump administration. But plenty of scientists and policy have quietly taken the so-called "lab-leak hypothesis" seriously and now that the volume has been lowered on some of Trump's more dangerous distortions they're starting to...
2021-02-081h 24CORONAVIRUS. COVID-1952-LOS ANTIINFLAMATORIOS NO ESTEROIDES DISMINUYEN LOS ANTICUERPOS A LA INFECCIÓN POR SARS-COV-2. UNA HIPÓTESIS QUE SE PLANTEA.Los AINE inhiben las enzimas ciclooxigenasa-1 (COX-1) y ciclooxigenasa-2 (COX-2), que median en la producción de prostaglandinas (PG). Dado que los PG desempeñan diversas funciones biológicas en la homeostasis y las respuestas inflamatorias, la inhibición de la producción de PG con AINE podría afectar la patogénesis de COVID-19 de múltiples maneras, que incluyen:
1-Alterar la susceptibilidad a la infección modificando la expresión de la enzima convertidora de angiotensina 2 (ACE2), el receptor de entrada celular para el SARS-CoV-2.
2-Regular la replicación de SARS-CoV-2 en células huéspe...
2021-01-2104 minMicro binfie podcast42 Overcoming barriers to SARS-CoV-2 data analysisARTICnetwork & CLIMB-BIG-DATA present a panel discussion on overcoming barriers to SARS-CoV-2 data analysis with Nick Loman and Will Rowe from the University of Birmingham, Áine O'Toole from the University of Edinburgh, Andrew Page from the Quadram Institute and Anna Price from MRC CLIMB and Cardiff University. This was part of a workshop on COVID-19 data analysis.
Topics covered:
Collecting sample metadata
intrapatient variability
Building bridges with policy makers to start sequencing
Data sharing
Improving bioinformatics skills
Pipeline and software validation
Bioinformatics reproducibility and quality
Papers:
The PHA4GE SARS-CoV-2 Contextual Data Specification for Open Genomic Epidemiology https://www.preprints.org/m...
2021-01-2046 minMicro binfie podcast41 SARS-CoV-2 Phylogenomics questions answeredARTICnetwork & CLIMB-BIG-DATA present a panel discussion on SARS-CoV-2 phylogenomics with Nick Loman from the University of Birmingham, Verity Hill from the University of Edinburgh, Andrew Page from the Quadram Institute and Anna Price from MRC CLIMB and Cardiff University. This was part of a workshop on COVID-19 data analysis.
The topics covered are:
More about Polecat
Whats the difference between COG-UK Phylotypes and Pangolin lineages?
What is the difference between Civet and Llama
Can you use BLAST to find similar SARS-CoV-2 genomes?
How do you find similar sequences in the public repositories to give your samples context?
How do you...
2021-01-1925 minMicro binfie podcast40 A crash course in SARS-CoV-2 bioinformaticsOver the last year we've learnt a lot about SARS-CoV-2 genomics. Lee extracts all the insider knowledge from our brains and we give him the honest truth to his probing questions.
We cover:
Pipelines for SARS-CoV-2
Archives & metadata
Read filtering
Assembly vs consensus
Amplicon data analysis
Controls
If things look too good
Coverage
....
Some URLs:
https://github.com/connor-lab/ncov2019-artic-nf
https://github.com/jts/ncov-tools
https://github.com/lskatz/SARS-CoV-2-trueTree
2021-01-1857 min
Connect mit DJ Salsa Verde#003 - [SOLO]: Ursprung von SARS-CoV-2Es erwartet euch die erste Solo-Folge. Es geht um den Ursprung des SARS-CoV-2 Virus
und Wissenschaft im allgemeineren (da schweife ich am anfang etwas in die Physik ab).
Wie in der Folge angekündigt, hier die Links zu Zeitungsartikeln und Papern zum nachlesen:
Neue Züricher Zeitung (vom 08.06.2020)
https://www.msn.com/de-ch/nachrichten/international/niederlande-t%C3%B6ten-tausende-nerze-wegen-sars-cov-2-%E2%80%93-%C3%BCbertragung-auf-menschen-vermutet/ar-BB151p0k
Die Rheinlandpfalz (vom 21.12.2020)
https://www.rheinpfalz.de/panorama_artikel,-d%C3%A4nemark-will-gekeulte-nerze-wieder-ausgraben-und-verbrennen-_arid,5148330.html
CNN Corona-Timeline: https://edition.cnn.com/2020/02/06/health/wuhan-coronavirus-timeline-fast-facts/index.html
Pa...
2021-01-0150 minCORONAVIRUS. COVID-1946-IMPLICACIONES DE LA VARIANTE EMERGENTE DE SARS-COV-2. SEGÚN CDC. ACTUALIZACIÓN A LA FECHA.Los CDC comunicarán la nueva información contestando 9 preguntas así:
Primera ¿Esta variante tiene nombre?
En la actualidad, la variante se conoce como "SARS-CoV-2 VOC 202012/01
Segunda ¿Por qué esta variante ha aparecido en las noticias recientemente?
Desde noviembre de 2020, una cepa variante del SARS-CoV-2 se ha vuelto prevalente en el sureste de Inglaterra.
Tercera ¿Por qué ha surgido esta variante en el Reino Unido?
No sabemos.
Cuarta ¿Hemos visto esta variante en América?
La variante VOC 202012/01 no se ha identificado.
Quinta...
2020-12-2913 min
Berita RadarEpisode 14: Menristek Angkat Suara soal SARS-Cov-2 Varian InggrisIndonesia perlu mewaspadai varian baru virus SARS- CoV-2 yang disebut sudah bermutasi di Inggris. Virus penyebab Covid-19 ini punya daya tular tinggi dan cepat penyebarannya.
Menristek, Bambang Brodjonegoro mengatakan, adanya temuan mutasi ini tidak boleh dianggap remeh. Virus SARS-CoV-2 ini tergolong paling besar dalam keluarga virus corona. Keluarga virus corona ini banyak dan berapa di antaranya sudah jadi wabah seperti SARS, Mers, dan sekarang SARS-CoV-2.
2020-12-2453 min
infektiopodInfektiopod#41 Covid-19: Testing: PCR, Antigen-Tests und neue SARS-CoV-2 Variante B.1.1.7. aka VOC 202012/01In der Vorweihnachts-Folge Nr. 41 des Infektiopods beschäftigen wir uns endlich mit Testungen auf SARS-CoV-2 und zwar zusammen mit einer echten Expertin in Sachen Coronavirus-Diagnostik: Dr. Susanne Pfefferle ist Virologin am UKE und hat schon zu SARS-CoV-1 geforscht. Wir besprechen im Detail PCR (Vorsicht Nerd-Faktor!), Antigen- und Antikörpertests. Außerdem sprechen wir über die neue (mutierte) … „Infektiopod#41 Covid-19: Testing: PCR, Antigen-Tests und neue SARS-CoV-2 Variante B.1.1.7. aka VOC 202012/01“ weiterlesen
2020-12-2300 minCORONAVIRUS. COVID-1944-VARIANTE DEL SARS-COV-2 CON MÚLTIPLES MUTACIONES DE PROTEÍNAS PICO OBSERVADAS EN EL REINO UNIDO. AUMENTO RÁPIDO SEGÚN ECDC.La nueva variante se define por múltiples mutaciones de proteínas pico presentes, así como mutaciones en otras regiones genómicas.
Se necesitan esfuerzos oportunos para prevenir y controlar su propagación, que incluyen los siguientes 6 puntos:
1- Se insta a las autoridades y laboratorios de salud pública a analizar y secuenciar los aislados de virus de manera oportuna para identificar los casos de la nueva variante. Las personas con un vínculo epidemiológico con casos con la nueva variante o antecedentes de viajes a áreas que se sabe están afectadas deben ser...
2020-12-2206 min
PROYECCIONES 2020 - EPISODIO 1PROYECCIONES 2020 EP 208 ¿Vuelta a foja cero? Por qué la nueva mutación del SARS-CoV-2 preocupa tanto a los científicosOPINION DEL DR. FERNANDO POLLACK
La aparición de la nueva mutación del virus SARS-CoV-2 llamado N501Y, en Reino Unido, pone nuevamente en vilo a todo el mundo, en un momento donde la llegada de las vacunas permitían imaginar que el mundo volvería de a poco a la “vieja normalidad”.
Pero, ¿qué se sabe de esta nueva cepa? Tras notar un aumento de casos tanto de contagios como de fallecidos en Reino Unido, de acuerdo a la revista Science, el 8 de diciembre, científicos y expertos en salud pública llegaron a la conclus...
2020-12-2127 min
infektiopodInfektiopod#40 Covid-19: SARS-CoV-2 Impfstoffe: ChAdOx (AZD1222) efficacy paper, STIKO-Empfehlungen & SchwangerschaftWir machen weiter mit den papern zur Wirksamkeit (efficacy) der SARS-CoV-2 Impfstoffe und besprechen heute die Veröffentlichung zum ChAdOX-Impfstoff „AZD1222“. Das paper ist etwas schwer zu verdauen aber enthält einige interessante Befunde, u.a. zum Schutz vor asymptomatischen SARS-CoV-2 Infektionen. Außerdem geht es um die aktuellen STIKO-Empfehlungen (wer wird wann geimpft?) und um Impfungen in der … „Infektiopod#40 Covid-19: SARS-CoV-2 Impfstoffe: ChAdOx (AZD1222) efficacy paper, STIKO-Empfehlungen & Schwangerschaft“ weiterlesen
2020-12-1800 min
Beyond ResearchTesting the Wastewaters: Researchers Develop a Fast and Effective Method for Detecting SARS-CoV-2Since the on-set of the pandemic, researchers around the world in diverse fields of study have pivoted their work to support the fight against COVID-19. Dr. Amina Stoddart, an assistant professor in Dalhousie University’s department of civil and resource engineering and researcher at the Centre for Water Resources Studies, is no different. Listen as she explains how her research team is using their expertise in water treatment to design an ingenious method to detect the COVID-19 virus. Find our transcript here: https://researchns.ca/beyondresearch-testing-the-wastewaters-detecting-sars-cov-2/ In Season 1, Episode 7 – Testing the Wastewa...
2020-11-3017 min
F.A.Z. WissenWie gut schützen Masken vor Sars-CoV-2?FAZ Wissen
Aktueller Review:
S. Kumar & H. P. Lee, 24.11.2020, "The perspective of fluid flow behavior of respiratory droplets and aerosols through the facemasks i context of Sars-CoV-2", Physics of Fluids
Aktuelle Studie zur Wirksamkeit von 11 verschiedenen Gesichtsbedeckungen:
J. Pan et al., 20.11.2020, "Inward and outward effectiveness of cloth masks, a surgical mask, and a face shield", medRxiv
Dänische Studie zur Wirksamkeit von Masken vor Ansteckung:
Bundgaard et al., 18.11.2020, "Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers - A Randomized Controlled Trial", Annals of I...
2020-11-2630 min
MINUTO COVID-19Episódio 15: Possibilidade de reinfecção pelo SARS-CoV-2O nosso episódio 15 foi produzido para esclarecer sobre a possibilidade de reinfecção pelo SARS-CoV-2. Por isso, é necessário reafirmar que saem atualizações sobre o tema a todo momento. Pedimos que você acompanhe o nosso episódio e compartilhe com seus colegas para que possam ter acesso a ele também!
Dúvidas ou sugestões: @minutocovid_19
REFERÊNCIAS:
BONIFÁCIO, Lívia Pimenta et al. Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil. Revista da Sociedade Brasileira de Medicina Tropical, v. 53, 2020.
DENG, Wei et al. Primary exp...
2020-11-1907 min
Más que Urgencias y EmergenciasEP23. Aerosoles y COVID-19: la transmisión aérea del SARS-CoV-2.Cierro la segunda temporada de Más que urgencias y emergencias con el episodio 23 llamado Aerosoles y COVID-19: la transmisión aérea del
SARS-CoV-2.
En este episodio os cuento que hay un grupo de casi 250 científicos que afirman que hay evidencia científica abrumadora de que el SARS-CoV-2 se transmite por el aire. Algunos países, la OMS y la CDC siguen sin reconocerlo. El hecho de que las partículas mayores de 5 micrómetros permanezcan suspendidas en el aire cuando nos creíamos que no lo hacían, hace que los interiores sin ventilación sean un caldo de cu...
2020-10-1444 min
Eazy SenseEazy Sense (50) SARS-CoV-2 effect on the brainSARS-CoV-2 affects the brain.Measure your blood oxygen level, ECG from anywhere and see how fit you are -SURELY, BUT CAN YOU SEE ON YOUR CELL PHONE ANY OF YOUR NEUROTRANSMITTERS SUCH AS DOPAMINE AND SEROTONIN? CAN YOU SEE HOW YOU FEEL? CAN YOU SEE HOW YOUR MEDICATIONS HAVE AFFECTED YOUR NEUROTRANSMITTER? ARE YOUR NEUROTRANSMITTERS IN GOOD ORDER? OUR SHOW TONIGHT IS ABOUT THE BRODERICK PROBE, a tiny sensing device.They are so sturdy. They do not break if you were to drop them. They make sense. Sensors make sense.After all...
2020-10-0158 minMicro binfie podcast31 Large scale sequencing of SARS-CoV-2 genomes from one regionWe chat to Justin O'Grady, Andrew Page and Alison Mather about how they went about sequencing 1500 SARS-CoV-2 genomes from one small region in the UK (Norfolk), and how they went about using the data for genomic epidemiology to help get a detailed, near real-time view of the pandemic as it unfolded.
Some of the key points are that in Norfolk and surrounding regions:
100 distinct UK lineages were identified.
16 UK lineages found in key workers were not observed in patients or in community care.
172 genomes from SARS-CoV-2 positive samples sequenced per 100,000 population representing 42.6% of all positive cases.
SARS-CoV-2 genomes from 1035 cases...
2020-10-0153 min
Bericht für die Lebensmittelbranche#046 Arbeitsmedizinische Empfehlung und SARS-CoV-2-Arbeitsschutzregel: aktuelle Vorgaben für BetriebsInhaltDas Bundesministerium für Arbeit und Soziales hat kurz nacheinander zwei Papiere Veröffentlicht: die Empfehlung „Umgang mit aufgrund der SARS-CoV-2-Epidemie besonders schutzbedürftigen Beschäftigten" und eine aktuelle Fassung der „SARS-CoV-2-Arbeitsschutzregel". Nun gilt es, diese im Betrieb umzusetzen. Was neu ist bzw. erweitert wurde, erfahren Sie in dieser Folge. Ihre Experte Prof. Dr. Ulrich Nöhle Öffentlich bestellter und vereidigter Sachverständiger für Lebensmittelsicherheit und Hygiene Kontaktdaten Tel.: 0170 188 1652 E-Mail: ulrich.noehle@web.de Weiter Informationen zum Thema dieser Folge Online-Sem...
2020-08-3148 minThis Week in VirologyShane Crotty on SARS-CoV-2 immunityImmunologist Shane Crotty joins TWiV to discuss the antibody and T cell responses to infection with SARS-CoV-2, followed by answers to listener questions. Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker Guest: Shane Crotty Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Ahead of the Curve by Shane Crotty SARS-CoV-2 T cell epitopes (Cell) Cross-reactive CoV T cell epitopes (Science) Knowns and unknowns about SARS-CoV-2 immunity (Nat Rev Imm) Letters read on TWiV 657 Timestamps by Jolene. Thanks! Intro mu...
2020-08-272h 13
Salud con TALASALUD ConTALA 60 ❤ RADAR COVID // SARS-COV-2 está hace 50 años en Murciélagos // Dietas respaldadas por la cienciaConTALA SALUD 60 ❤ RADAR COVID // SARS-COV-2 está hace 50 años en Murciélagos // Dietas respaldadas por la ciencia
Radar COVID, la app que avisa de la proximidad de casos positivos de coronavirus
El SARS-CoV-2 lleva entre 70 y 40 años en los murciélagos y lo más probable es que saltara directamente a humanos
Las dietas para adelgazar que la ciencia respalda (y las que no)
FUENTES:
https://www.efesalud.com/radar-covid-aplicacion-proximidad-positivos-de-coronavirus/
https://www.agenciasinc.es/Noticias/El-SARS-CoV-2-lleva-entre-70-y-40-anos-en-los-murcielagos-y-lo-mas-probable-es-que-saltara-directamente-a-humanos
https://www.elconfidencial.com/alma-corazon-vida/2020-08-01/l...
2020-08-2016 minMicro binfie podcast26 SARS-CoV-2 contextual data specification for open genomic epidemiologyWe talk to Dr Emma Griffiths (UBC), Dr Ruth Timme (FDA) and Dr Duncan MacCannell (CDC) about the PHA4GE SARS-CoV-2 contextual data specification for open genomic epidemiology.
Paper: https://www.preprints.org/manuscript/202008.0220/v1
Specification: https://github.com/pha4ge/SARS-CoV-2-Contextual-Data-Specification
Protocols: https://www.protocols.io/workspaces/pha4ge
The Public Health Alliance for Genomic Epidemiology (PHA4GE) (https://pha4ge.org) is a global coalition that is actively working to establish consensus standards, document and share best practices, improve the availability of critical bioinformatic tools and resources, and advocate for greater openness, interoperability, accessibility and reproducibility in...
2020-08-1337 min
COVID19 Road to a vaccineVaccine approaches and immunological aspects of SARS-CoV-2 with Professor Katie FlanaganIn episode 8 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford, speaks with Professor Katie Flanagan. Katie is Head of Infectious Diseases at Launceston General Hospital and is affiliated with the University of Tasmania, Monash University and RMIT where she is involved in a broad range of research projects, with her main interests being in vaccinology and infectious diseases immunology. She has led a number of vaccine immunology trials. In this episode they discuss:•Immunological aspects of SARS-CoV-2•Vaccine responses in adults versus children and the difference in adult immune systems•Vaccin...
2020-08-0331 min
The Rounds TableEpisode 14 – Rapid Fire SARS-CoV-2 VaccinesSend us a textWelcome back Rounds Table Listeners! This week we are going back to our Rapid Fire Format to review two papers looking at potential SARS-CoV-2 vaccines. What is the safety profile and immune system response for a novel SARS-CoV-2 specific vaccine? https://www.nejm.org/doi/full/10.1056/NEJMoa2022483 (1:05-8:44) What is the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine ...The post Episode 14 – Rapid Fire SARS-CoV-2 Vaccines appeared first on Healthy Debate.
2020-07-3120 min
Contagium's podcastEP 186. ¿ Es SARS-CoV-2 transmitido por aerosoles?En el programa de hoy comentamos sobre la controversia alrededor del modo de transmisión de SARS-CoV-2: ¿aerosol o gotitas? Referencias: Derek Chu y colaboradores. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. R. Zhang y colaboradores. Identifying airborne transmission as the dominant route for the spread of […]
The post EP 186. ¿ Es SARS-CoV-2 transmitido por aerosoles? appeared first on Contagium.
2020-06-2100 minCOVID19 Road to a vaccineThe specific virus characteristics of SARS-CoV-2 with Professor Kanta SubbaraoIn episode 4 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford, will be speaking to Professor Kanta Subbarao. Professor Subbarao has been the Director of the World Health Organisation Collaborating Centre for Reference and Research on Influenza since 2016, based at The Doherty Institute at the University of Melbourne, Australia. She is a virologist and physician who specialises in paediatric infectious diseases. Her research is focused on influenza, as well as newly emerging viral diseases of global importance such as SARS and MERS, which includes immune responses to infection and vaccination. In this episode...
2020-06-1530 min
CAPcast from the College of American PathologistsUsing Proficiency Testing to Ensure Accurate Serologic Testing of SARS-CoV-2As we move into the next phase of the pandemic, laboratories are ramping up efforts to implement SARS-CoV-2 antibody testing to identify individuals who may have been infected with SARS-CoV-2 in the past.
In this CAPcast, Dr. Daniel Rhoads, Section Head of Microbiology at the Cleveland Clinic and Dr. Elitza Theel, Director of Infectious Disease Serology from Mayo Clinic explain the clinical use of antibody testing for SARS-CoV-2 and describe the work of the CAP’s Microbiology and Diagnostic Immunology and Flow Cytometry Committees to develop the new proficiency testing program SARS-CoV-2 Serology (COVS).
The new SARS-CoV-2 Serology PT program is...
2020-05-2608 min
infektiopodInfektiopod#26 Covid-19: BCG-Impfstoff zum Schutz vor SARS-CoV-2 & ‚Human Challenge Models‘Können Lebendimpfstoffe gegen Kinderlähmung (Polio), Masern oder Tuberkulose (BCG) eine unspezifische antivirale Wirkung gegen SARS-CoV-2 vermitteln? Was sind Immunologische Hypothesen für diese unspezifische protektive Wirkungen von Lebendvakzinen? Und darf man Gesunde Proband*innen mit SARS-CoV-2 infizieren („human challenge models“) um die Forschung an einem Impfstoff voranzutreiben? Diese spannenden Fragen diskutieren wir heute zu dritt. Till Koch … „Infektiopod#26 Covid-19: BCG-Impfstoff zum Schutz vor SARS-CoV-2 & ‚Human Challenge Models‘“ weiterlesen
2020-05-1242 min
Podcastul Raportuldegardă.ro#RaportuldeGarda. Pastila de Inovație #COVID19: Imunitatea colectivă în contextul SARS-CoV-2Am descoperit tratamentul pentru infodemia #COVID19: Pastila de inovație, administrată în fiecare zi de luni pe toate platformele #Raportuldegarda (Website, Podcast, YouTube, Facebook) și simultan către audiența a peste 90 de posturi locale de #Radio și peste 50 posturi locale de #Televiziune.
🎧 https://anchor.fm/raportuldegarda
💊 A șasea pastilă de inovație abordează imunitatea colectivă sau imunitatea de turmă (herd immunity), care poate împiedica răspândirea unei infecții într-o populație, atunci când o proporție suficientă de persoane sunt imune la boală. Zilele trecute s-au împlinit 40 de ani de la eradicarea oficială a variolei...
2020-05-1105 min
The Pragati PodcastEp. 136: The SARS-COV-2 Virus: Mutations & EvolutionThe SARS-COV-2 virus started infecting humans in Wuhan in late 2019. How has the virus mutated and evolved so far? With 1-2 mutations occurring per month, researchers are now seeing a clade or a sub-type of the virus: A2a, becoming more common in COVID-19 infections across the world.Partha Majumder, NIdhan Biswas and their colleagues at the National Institute of Biomedical Genomics have done seminal work on analyzing the mutations and evolution of the SARS-COV-2 virus so far.Partha Majumder, one of India's foremost researchers in statistical genomics and human genome variation, joins Pavan Srinath...
2020-05-0800 min
Infos coronavirusDisparités et inégalités face au coronavirus SARS-CoV-2: ce qu'il faut retenirNous ne sommes pas tous égaux face au virus. Le SARS-CoV-2 frappe plus durement certaines personnes. Beaucoup de choses ont été dites puis contredites. Les enfants qui seraient moins vecteur, les fumeurs qui seraient moins infectés. Le point sur ces différences face au virus. • L’âge, un facteur déterminantLe virus touche tout le monde, mais pas avec la même puissance. L’âge est le plus gros facteur de disparité entre individus face au virus. Les personnes de plus de 70 ans sont les plus représentées parmi les morts de la maladie Covid-1...
2020-04-3004 min
Ay Up AI#4 | Bug-Busting AI: Research and Development on a SARS-CoV-2 VaccineA groundbreaking new vaccine against SARS-CoV-2 virus has been developed in just 2 days!
How has AI helped us better understand the structure of SARS-CoV-2 virus?
Who is making the SARS-CoV-2 vaccine?
How are they making it?
How long will it take?
Hear us discuss these and more about how global collaboration is facilitating innovation at an unprecedented pace.
2020-04-2815 min
Radio 1 – TalkradioWissenschaft zu Sars-CoV-2 - Folge 21Wissenschafts-Journalist Beat Glogger, der Gründer der Internet-Wissensplattform Higgs.ch und Radio 1-Chefredaktor Jan Vontobel diskutieren jeweils Montags, Mittwochs und Freitags um 16 Uhr Hintergründe über das neuartige Coronavirus Sars-CoV-2. Können Kleinkinder gefahrenlos umarmt werden ohne ein Risiko einzugehen sich mit Sars-Cov-2 zu infizieren? Wissenschaftler weltweit sind sich nicht sicher. In der 21. Ausgabe der Sendung Wissenschaft zu Sars-CoV-2 ordnet Beat Glogger ein. Und gibt auch Antworten auf die Frage, ob eine zweite Welle der Pandemie droht und ob diese heftiger ausfallen wird als die erste. Haben Sie Fragen oder Inputs für die Sendung? Schreiben Sie ein Mail an wisse...
2020-04-2700 minThis Week in VirologySARS-CoV-2 - enter the CoronialsDaniel Griffin joins TWiV to update on the clinical situation, then we discuss a 382 nucleotide deletion in the SARS-CoV-2 genome, a scenario for emergence of the virus from a bat, followed by answers to listener email. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, Kathy Spindler, and Brianne Barker Guest: Daniel Griffin Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode 382 nt deletion in genome of SARS-CoV-2 (bioRxiv) Recombination and mutation leading to SARS-CoV-2 (bioRxiv) Letters read on TWiV 600 Timestamps by Jolen...
2020-04-121h 53